Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

A novel curcumin-based vaginal cream Vacurin selectively eliminates apposed human cervical cancer cells.

Debata PR, Castellanos MR, Fata JE, Baggett S, Rajupet S, Szerszen A, Begum S, Mata A, Murty VV, Opitz LM, Banerjee P.

Gynecol Oncol. 2013 Apr;129(1):145-53. doi: 10.1016/j.ygyno.2012.12.005. Epub 2012 Dec 9.

PMID:
23234806
2.

Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7.

Maher DM, Bell MC, O'Donnell EA, Gupta BK, Jaggi M, Chauhan SC.

Mol Carcinog. 2011 Jan;50(1):47-57. doi: 10.1002/mc.20695.

PMID:
21061268
5.
6.

Curcumin counteracts the proliferative effect of estradiol and induces apoptosis in cervical cancer cells.

Singh M, Singh N.

Mol Cell Biochem. 2011 Jan;347(1-2):1-11. doi: 10.1007/s11010-010-0606-3. Epub 2010 Oct 13.

PMID:
20941532
7.

Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.

Ahn WS, Bae SM, Lee KH, Lee JM, Namkoong SE, Chun HJ, Kim CK, Kim YW.

Gynecol Oncol. 2004 Feb;92(2):611-21.

PMID:
14766255
8.

Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.

Li B, Hu Y, Ye F, Li Y, Lv W, Xie X.

Int J Gynecol Cancer. 2010 May;20(4):597-604. doi: 10.1111/IGC.0b013e3181d63170.

PMID:
20442590
10.

Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.

Munagala R, Kausar H, Munjal C, Gupta RC.

Carcinogenesis. 2011 Nov;32(11):1697-705. doi: 10.1093/carcin/bgr192. Epub 2011 Aug 22.

PMID:
21859835
11.

RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.

Putral LN, Bywater MJ, Gu W, Saunders NA, Gabrielli BG, Leggatt GR, McMillan NA.

Mol Pharmacol. 2005 Nov;68(5):1311-9. Epub 2005 Aug 24.

12.

In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.

Madrigal M, Janicek MF, Sevin BU, Perras J, Estape R, PeƱalver M, Averette HE.

Gynecol Oncol. 1997 Jan;64(1):18-25.

PMID:
8995542
13.

Extended effects of human papillomavirus 16 E6-specific short hairpin RNA on cervical carcinoma cells.

Bai L, Wei L, Wang J, Li X, He P.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):718-29.

PMID:
16681752
14.

The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.

Pillai MR, Halabi S, McKalip A, Jayaprakash PG, Rajalekshmi TN, Nair MK, Herman B.

Cancer Epidemiol Biomarkers Prev. 1996 May;5(5):329-35.

16.
17.

Notch1 can contribute to viral-induced transformation of primary human keratinocytes.

Lathion S, Schaper J, Beard P, Raj K.

Cancer Res. 2003 Dec 15;63(24):8687-94.

18.

Inhibition of HPV 16 E6 oncogene expression by RNA interference in vitro and in vivo.

Niu XY, Peng ZL, Duan WQ, Wang H, Wang P.

Int J Gynecol Cancer. 2006 Mar-Apr;16(2):743-51.

PMID:
16681755
19.
20.

Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.

Sima N, Wang S, Wang W, Kong D, Xu Q, Tian X, Luo A, Zhou J, Xu G, Meng L, Lu Y, Ma D.

Gynecol Oncol. 2007 Aug;106(2):299-304. Epub 2007 Jun 21.

PMID:
17586029

Supplemental Content

Support Center